PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1354720
PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1354720
The global Specimen Collection Cards Market is poised for substantial growth, with a forecasted market size of approximately US$650 million by the end of 2030. This expansion is expected to occur at a healthy CAGR of 6% from 2023 to 2030, according to a comprehensive market analysis.
The increasing adoption of specimen collection cards is driven by their pivotal role in forensic toxicology and genetic testing. These cards have proven to be efficient and reliable tools for sample collection across various applications. Their advantages include noninvasiveness, reduced sample volume requirements, and enhanced sample stability during transportation and storage. These factors collectively enhance the accuracy and efficiency of forensic toxicological testing and genetic analysis.
The specimen collection cards market is poised for remarkable growth, with a projected revenue expansion of over 2x during the period from 2023 to 2030. Leading the market is the Whatman 903 product, which boasts superior sample retention capabilities, a reputable brand image, and user-friendly features. Additionally, cotton and cellulose-based materials dominate the market due to their exceptional absorbent properties, biocompatibility, and cost-effectiveness. Regionally, North America is set to maintain its leadership position, while Asia Pacific is expected to experience the most significant growth in the specimen collection cards market until 2030.
Prominent players in the specimen collection cards market include: QIAGEN, PerkinElmer Inc., DBS System SA, Danaher Corporation, Eastern Business Forms, Inc., Ahlstrom, ARCHIMED Life Science GmbH, GenTegra LLC, FortiusBio, and CENTOGENE N.V.